Drug Shortage Report for APO-ALENDRONATE

Last updated on 2018-03-27 History
Report ID 25204
Drug Identification Number 02248727
Brand name APO-ALENDRONATE
Common or Proper name ALENDRONATE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BLS
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-09
Estimated end date 2018-03-30
Actual end date 2018-03-26
Shortage status Resolved
Updated date 2018-03-27
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2018-03-27 French Compare
v14 2018-03-27 English Compare
v13 2018-03-05 French Compare
v12 2018-03-05 French Compare
v11 2018-03-05 French Compare
v10 2018-03-05 English Compare
v9 2018-03-05 English Compare
v8 2018-02-12 French Compare
v7 2018-02-12 English Compare
v6 2018-01-08 French Compare
v5 2018-01-08 English Compare
v4 2018-01-03 French Compare
v3 2018-01-03 English Compare
v2 2017-10-11 French Compare
v1 2017-10-11 English Compare